|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T85.43XA |
Leakage of breast prosthesis and implant, initial encounter
|
T8543XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 54.90%
|
23.48%
|
8.71%
|
4.50%
|
2.80%
|
1.86%
|
1.26%
|
0.63%
|
0.37%
|
0.51%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.43XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
520
|
1,053
|
|
J2405
|
ONDANSETRON HCL INJECTION |
496
|
2,227
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
493
|
2,004
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
451
|
16,083
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
411
|
2,790
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
395
|
4,086
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
376
|
377
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
282
|
566
|
|
J7120
|
RINGERS LACTATE INFUSION |
246
|
361
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
244
|
367
|
|
88300
|
SURGICAL PATH GROSS |
243
|
337
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
224
|
465
|
|
19371
|
PERI-IMPLT CAPSLC BRST COMPL |
221
|
221
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
218
|
346
|
|
19330
|
RMVL RUPTURED BREAST IMPLANT |
191
|
191
|
|
77047
|
MRI BREAST C- BILATERAL |
191
|
191
|
|
19342
|
INSJ/RPLCMT BRST IMPLT SEP D |
188
|
188
|
|
J1170
|
HYDROMORPHONE INJECTION |
178
|
309
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
177
|
292
|
|
C8908
|
MRI W/O FOL W/CONT, BREAST, |
163
|
163
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.43XA related to the following DRG Codes:
600-601
|
